Rationale And Objectives: The goal of mammography screening is to detect breast cancer at early stages, but because of the complexity of the breast parenchyma and the variability of signs of the disease, many cancers go unreported when initially visible on the mammogram. We compared the visual search strategy used by experienced mammographers in a case set where they examined both the mammogram in which a malignant mass was discovered at screening mammography and the most recent prior mammogram.
Materials And Methods: Four experienced mammographers participated in this experiment. They read a case set of 20 two-view mammograms, of which 15 contained a malignant mass and 5 were lesion-free, in two trials. For each of the cancer cases, two versions were shown to the observers: the one in which the cancer was reported in the clinical practice, called the "current" mammograms, and the most recent prior. Each trial had a balanced mix of current and prior mammograms. In addition, the same set of lesion-free cases was shown to the observers in both trials. The eye movements of the observers were tracked, and visual search parameters such as time to hit the location of the malignant mass, dwell, and mean pupil size in the location of the cancer were collected. Statistical analyses were used to determine whether there were differences between the current and prior mammograms.
Results: A total of 66% of the malignant masses in the current mammograms and 57% in the priors attracted some amount of visual attention. From these, 71% yielded a report on the current mammograms, but only 40% on the priors. In the cases where the observer saw the malignant mass, they did so within 2 seconds of image display, regardless of whether the mammogram was current or prior.
Conclusion: Most unreported malignant masses attracted some amount of visual attention, but it was in the processing of the information extracted in the location of the lesion that most errors occurred. In our experiment, approximately 70% of the total time used by the observers for visual scan of the cases was spent gathering information to corroborate the hypothesis already formed by the radiologist.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.acra.2005.03.068 | DOI Listing |
Cell Div
January 2025
Babak Myeloma Group, Department of Pathophysiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
Background: Multiple myeloma (MM) represents the second most common hematological malignancy characterized by the infiltration of the bone marrow by plasma cells that produce monoclonal immunoglobulin. While the quality and length of life of MM patients have significantly increased, MM remains a hard-to-treat disease; almost all patients relapse. As MM is highly heterogenous, patients relapse at different times.
View Article and Find Full Text PDFWorld J Surg Oncol
January 2025
The Department of General Surgery, The Second Hospital of Jilin University, Changchun, 130041, China.
Background: Extraskeletal osteosarcoma (ESOS) is a rare kind of sarcoma with a low preoperative diagnosis and a poor prognosis. ESOS arising from abdominal mesentery is extremely rare. Increasing diagnostic methods and standardizing treatment protocols are crucial issues of ESOS.
View Article and Find Full Text PDFCell Death Dis
January 2025
Department of Pathology, Qilu Hospital and School of Basic Medical Sciences Shandong University, Jinan, Shandong, PR China.
Long noncoding RNAs (lncRNAs) are key regulators during gastric cancer (GC) development and may be viable treatment targets. In the present study, we showed that the expression of the long intergenic noncoding RNA 01016 (LINC01016) is significantly higher in GC tissues with lymph node metastasis (LNM) than those without LNM. LINC01016 overexpression predicts a poorer relapse-free survival (RFS) and overall survival (OS).
View Article and Find Full Text PDFGastroenterol Clin North Am
March 2025
Karsh Division of Gastroenterology and Hepatology, Cedars-Sinai Medical Center, 8700 Beverly Boulevard, ST, Suite 7705, Los Angeles, CA 90048, USA. Electronic address:
Pancreatic cancer, often diagnosed at advanced stages, has poor survival rates. Effective screening aims to detect the disease early, improving outcomes. Current guidelines recommend screening high-risk groups, including those with a family history or genetic predispositions, using methods like endoscopic ultrasound and MRI.
View Article and Find Full Text PDFBMJ Case Rep
January 2025
ARHC/Stroke Service, Naas General Hospital, Naas, Kildare, Ireland.
A woman in her early 60s presented with multiple transient neurological symptoms over the course of 20 months, including transient loss of power to her right lower limb. Initial workup with CT brain scan, carotid dopplers and ECG revealed no abnormality; however, MRI of the brain suggested recent ischaemic events in separate cortical territories. Subsequent transoesophageal echocardiogram revealed a large mobile mass histologically confirmed to be an atrial myxoma.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!